Aim and objective: The purpose of this study was to evaluate and compare the changes in the release of vascular endothelial growth factor (VEGF) from platelet-rich fibrin (PRF) as well as the changes observed in the fibrin architecture of PRF when layered with mineral trioxide aggregate (MTA), Biodentine, and Theracal.
Materials and methods: Platelet-rich fibrin was obtained from eight volunteers to form PRF membrane (PRFm) and divided into four groups of control (PRF alone), PRF with MTA, PRF with Biodentine, and PRF with Theracal by layering the PRFm over with these materials. Four samples of each group were prepared. Release of VEGF was estimated using enzyme-linked immunosorbent assay (ELISA) at 1 hour and 5 hours. PRFm in contact with the materials was analyzed under a scanning electron microscope to observe the fibrin architecture.
Results: A significantly higher amount of VEGF was released from the Theracal group as compared to control (PRF only), Biodentine, and MTA. The fibrin architecture of the Biodentine group was more similar to that of the control group at both 1 hour and 5 hours.
Conclusion: Theracal could be a suitable material to be used along with PRF for endodontic use wherever indicated.
Clinical significance: The results show an increased release of VEGF from PRFm when layered with Theracal. PRFm used in procedures like revascularization and pulpotomy may therefore be layered with these dental materials to enhance the regeneration and create a biocompatible seal.
Choukroun J, Adda F, Schoeffler C, et al. Une opportunité en paro-implantologie: le PRF. Implantodontie 2000;42:55–62.
Dohan Ehrenfest DM, de Peppo GM, Doglioli P, et al. Slow release of growth factors and thrombospondin-1 in Choukroun's platelet-rich fibrin (PRF): a gold standard to achieve for all surgical platelet concentrates technologies. Growth Factors 2009;27(1):63–69. DOI: 10.1080/08977190802636713.
Toffler M, Toscano N, Holtzclaw D, et al. Introducing Choukroun's platelet rich fibrin (PRF) to the reconstructive surgery milieu. J Implant Adv Clin Dent 2009;2586:2086.
Su CY, Kuo YP, Tseng YH, et al. In vitro release of growth factors from platelet-rich fibrin (PRF): a proposal to optimize the clinical applications of PRF. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009;108(1):56–61. DOI: 10.1016/j.tripleo.2009.02.004.
Gandolfi M, Siboni F, Polimeni A, et al. In vitro screening of the apatite-forming ability, biointeractivity and physical properties of a tricalcium silicate material for endodontics and restorative dentistry. Dent J 2013;1(4):41–60. DOI: 10.3390/dj1040041.
Bortoluzzi EA, Niu L, Palani CD, et al. Cytotoxicity and osteogenic potential of silicate calcium cements as potential protective materials for pulpal revascularization. Dent Mat 2015;31(12):1510–1522. DOI: 10.1016/j.dental.2015.09.020.
Wattanapakkavong K, Srisuwan T. Release of transforming growth factor beta 1 from human tooth dentin after application of either ProRoot MTA or biodentine as a coronal barrier. J Endod 2019;45(6):701–705. DOI: 10.1016/j.joen.2019.03.011.
Laurent P, Camps J, About I. BiodentineTM induces TGF‐β1 release from human pulp cells and early dental pulp mineralization. Int Endod J 2012;45(5):439–448. DOI: 10.1111/j.1365-2591.2011.01995.x.
Wahlstrom O, Linder C, Kal_en A, et al. Variation of pH in lysed platelet concentrates influence proliferation and alkaline phosphatase activity in human osteoblast-like cells. Platelets 2007;18(2):113–118. DOI: 10.1080/09537100600800537.
Zhang J, Liu X, Yu W, et al. Effects of human vascular endothelial growth factor on reparative dentin formation. Mol Med Rep 2016;13(1):705–712. DOI: 10.3892/mmr.2015.4608.
Matsushita K, Motani R, Sakutal T, et al. The role of vascular endothelial growth factor in human dental pulp cells: induction of chemotaxis, proliferation, and differentiation and activation of the AP-1-dependent signaling pathway. J Dent Res 2000;79(8):1596–1603. DOI: 10.1177/00220345000790081201.
Youssef AR, Emara R, Taher MM, et al. Effects of mineral trioxide aggregate, calcium hydroxide, biodentine and Emdogain on osteogenesis, odontogenesis, angiogenesis and cell viability of dental pulp stem cells. BMC Oral Health 2019;19(1):1–9. DOI: 10.1186/s12903-019-0827-0.
Mullaguri H, Suresh N, Surendran S, et al. Role of pH changes on transforming growth factor-β1 release and on the fibrin architecture of platelet-rich fibrin when layered with biodentine, glass ionomer cement and intermediate restorative material. J Endod 2016;42(5):766–770. DOI: 10.1016/j.joen.2016.02.009.
Paranjpe A, Smoot T, Zhang H, et al. Direct contact with mineral trioxide aggregate activates and differentiates human dental pulp cells. J Endod 2011;37:1691–1695.
Collen A, Koolwijk P, Kroon M, et al. Influence of fibrin structure on the formation and maintenance of capillary-like tubules by human microvascular endothelial cells. Angiogenesis 1998;2(2):153–165. DOI: 10.1023/A:1009240522808.
Joison AN, Gallo FS. Effect of time, pH, and doses to obtain in vitro efficient fibrinolysis with a new microplasmin: importance of results for future in vivo studies. Int J Appl Pharm Sci Res 2012;1:342–346.
Friedlander LT, Coates D, Seymour G, et al. Vascularity and VEGF/VEGFR2 signaling in the dentine-pulp complex of immature and mature permanent teeth. Eur Endod J 2018;3(3):153–159. DOI: 10.14744/eej.2018.07269.
Alazrag MA, Abu-Seida AM, El-Batouty KM, et al. Adaptability, solubility and biocompatibility of TheraCal LC compared with MTA-Angelus and biodentine as a furcation perforation repair material. Res Squ 2020. DOI: 10.21203/rs.3.rs-16588/v1.